Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.3K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.3K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

5.8K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
5.8K
Embryonic Stem Cells00:58

Embryonic Stem Cells

30.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
30.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.4K
Stem Cell Culture01:17

Stem Cell Culture

5.9K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Lipid Nanoparticles as Vehicles for Optogenetic Delivery in Primary Cortical Neurons.

Pharmaceutics·2026
Same author

Effect of salbutamol-based anti-asthmatic medication on surface roughness and color stability of different types of hybrid ceramics.

BDJ open·2025
Same author

Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2024
Same author

Expanding the horizon of transient CAR T therapeutics using virus-free technology.

Biotechnology advances·2024
Same author

Incidence of 99Tc-MDP uptake in the external occipital protuberance in the pediatric population: the new normal?

American journal of nuclear medicine and molecular imaging·2023
Same author

Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers.

Drug delivery·2023

Related Experiment Video

Updated: Dec 1, 2025

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
09:53

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow

Published on: July 15, 2016

8.4K

Mesenchymal Stem Cells: The Past Present and Future.

Noha Attia1,2,3,4, Mohamed Mashal5,6

  • 1Department of Basic Sciences, The American University of Antigua-College of Medicine, Coolidge, Antigua and Barbuda. Noha.attia@alexmed.edu.eg.

Advances in Experimental Medicine and Biology
|November 7, 2020
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells (MSCs) show great promise for regenerative medicine due to their self-renewal, differentiation, and immune-evasive properties. Further research is needed to optimize MSCs and overcome current limitations for broader clinical use.

Keywords:
Drug deliveryExtracellular vesiclesGene therapyMesenchymal stem cellsSecretome

More Related Videos

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.7K
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 1, 2025

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
09:53

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow

Published on: July 15, 2016

8.4K
Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.7K
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.6K

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Mesenchymal stem cells (MSCs) have garnered significant interest in biomedical applications over the last 30 years.
  • MSCs are readily sourced from various tissues, possess self-renewal capabilities, and can differentiate into multiple cell types.
  • Their immunomodulatory properties prevent graft rejection, and they exhibit homing abilities to target tissues for therapeutic effects.

Purpose of the Study:

  • To provide an overview of preclinical and clinical applications of MSCs in regenerative medicine.
  • To discuss the current limitations and future challenges associated with MSC-based therapies.

Main Methods:

  • Literature review of preclinical and clinical studies involving MSCs.
  • Analysis of MSC properties relevant to therapeutic applications.
  • Discussion of challenges and future research directions.

Main Results:

  • MSCs demonstrate potential in various regenerative medicine applications due to their unique biological characteristics.
  • Key properties include ease of acquisition, self-renewal, differentiation potential, immunomodulation, and tissue homing.
  • Despite their advantages, MSCs present limitations requiring further investigation for optimization.

Conclusions:

  • MSCs are promising candidates for cell and gene therapy across numerous clinical conditions.
  • Addressing existing limitations is crucial for enhancing MSC efficacy and expanding their therapeutic utility.
  • Continued research is essential for the full realization of MSC potential in regenerative medicine.